Mitochondrial dynamics are essential for neuronal health, enabling cells to adapt energy production and stress responses to changing demands. Although pathological Tau has been extensively linked to ...

Alzheimer's disease is a neurodegenerative disease characterized by a progressive decline in mental functions and memory loss. Along with frontotemporal dementia and some other neurodegenerative ...

Macquarie's Eugene Hsiao discusses the end of Moore's Law after Huawei introduces Tau Scaling Law. He sees convergence of chipmaking paths as the race for more cutting-edge chips continue. Meanwhile, ...

Huawei is proposing a new way to keep the semiconductor industry moving forward at a time when making smaller and smaller chips is becoming increasingly difficult. At the International Circuit Systems ...

In real life, Tau Ceti is the name of a star, approximately 12 light years away from Earth. It was first catalogued in 1603 by Johann Bayer, and as of this writing, astronomers estimate it has four ...

Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only newsletter about the crossroads of drug development, business, Wall Street, and ...

A phase 2 trial of Biogen and Ionis Pharmaceuticals’ tau-targeting candidate missed its primary endpoint. But while the Alzheimer’s disease trial failed to yield the hoped-for dose-response data, ...

All processes such as wound healing, hair growth, and the replacement of old cells with new ones depend on cell division. During this process, chromosomes inside the cell must be evenly divided ...

In Alzheimer’s disease, two key proteins, extracellular amyloid-beta plaques and an intercellular protein called tau, disrupt communication between the brain’s cells and lead to cell damage and death.

In the era of A.I. agents, many Silicon Valley programmers are now barely programming. Instead, what they’re doing is deeply, deeply weird. Credit...Illustration by Pablo Delcan and Danielle Del Plato ...

Summary: In the brains of patients with Alzheimer’s and Parkinson’s, proteins like Tau and alpha-synuclein act like “troublemakers,” misfolding and clumping together into toxic aggregates that kill ...

Analysts, investors and scientists are eager for Biogen’s 2026 BIIB080 readout. Even if successful, executives warn that there are many more steps before the Alzheimer’s therapy could reach the market ...